The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
1090415510 10904155 10 F 2015 20160818 20150311 20160826 EXP US-SA-2015SA019595 AVENTIS 52.00 YR A F Y 0.00000 20160826 CN US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
1090415510 10904155 1 PS LEMTRADA ALEMTUZUMAB 1 Intravenous drip U UNKNOWN 103948 12 MG CONCENTRATE FOR SOLUTION FOR INFUSION QD
1090415510 10904155 2 SS LEMTRADA ALEMTUZUMAB 1 Intravenous drip U UNKNOWN 103948 12 MG CONCENTRATE FOR SOLUTION FOR INFUSION QD
1090415510 10904155 3 SS LEMTRADA ALEMTUZUMAB 1 Intravenous drip U UNKNOWN 103948 12 MG CONCENTRATE FOR SOLUTION FOR INFUSION QD
1090415510 10904155 4 SS LEMTRADA ALEMTUZUMAB 1 Intravenous drip U UNKNOWN 103948 12 MG CONCENTRATE FOR SOLUTION FOR INFUSION QD
1090415510 10904155 5 SS LEMTRADA ALEMTUZUMAB 1 Intravenous (not otherwise specified) U UNKNOWN 103948 12 MG CONCENTRATE FOR SOLUTION FOR INFUSION QD
1090415510 10904155 6 SS AMPYRA DALFAMPRIDINE 1 Unknown U UNKNOWN 0
1090415510 10904155 7 C ZANTAC RANITIDINE HYDROCHLORIDE 1 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
1090415510 10904155 1 Multiple sclerosis relapse
1090415510 10904155 2 Multiple sclerosis relapse
1090415510 10904155 3 Multiple sclerosis relapse
1090415510 10904155 4 Multiple sclerosis relapse
1090415510 10904155 5 Multiple sclerosis relapse
1090415510 10904155 7 Premedication

Outcome of event

Event ID CASEID OUTC COD
1090415510 10904155 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
1090415510 10904155 Asthenia
1090415510 10904155 Burning sensation
1090415510 10904155 Confusional state
1090415510 10904155 Contusion
1090415510 10904155 Dysphonia
1090415510 10904155 Erythema
1090415510 10904155 Eye infection
1090415510 10904155 Fall
1090415510 10904155 Fatigue
1090415510 10904155 Feeling abnormal
1090415510 10904155 Haematochezia
1090415510 10904155 Headache
1090415510 10904155 Hypersensitivity
1090415510 10904155 Ill-defined disorder
1090415510 10904155 Laceration
1090415510 10904155 Malaise
1090415510 10904155 Mass
1090415510 10904155 Memory impairment
1090415510 10904155 Migraine
1090415510 10904155 Multiple sclerosis relapse
1090415510 10904155 Neck pain
1090415510 10904155 Oedema peripheral
1090415510 10904155 Pain in extremity
1090415510 10904155 Stomatitis
1090415510 10904155 Upper limb fracture
1090415510 10904155 Weight decreased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
1090415510 10904155 1 20150126 20150127 0
1090415510 10904155 2 20150129 20150130 0
1090415510 10904155 3 20160215 20160215 0
1090415510 10904155 4 20150202 20150202 0
1090415510 10904155 5 20160217 20160218 0